SDHB and neoplasm: Succinate increased as a result of SDH loss, is known to suppress the homologous recombination (HR) DNA-repair pathway required for the resolution of DNA double-strand breaks (DSBs), thus rendering tumor cells vulnerable to synthetic-lethal PARP inhibitors [54–56].